A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in SwedenJ. Andersson, Jonas Bergh, Gudrun Greim et al.|Acta Oncologica|2002Cited by 22